These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 21256914)

  • 21. Effects and safety of Psilocybe cubensis and Panaeolus cyanescens magic mushroom extracts on endothelin-1-induced hypertrophy and cell injury in cardiomyocytes.
    Nkadimeng SM; Steinmann CML; Eloff JN
    Sci Rep; 2020 Dec; 10(1):22314. PubMed ID: 33339902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphological and chemical analysis of magic mushrooms in Japan.
    Tsujikawa K; Kanamori T; Iwata Y; Ohmae Y; Sugita R; Inoue H; Kishi T
    Forensic Sci Int; 2003 Dec; 138(1-3):85-90. PubMed ID: 14642723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Consumption of psilocybin-containing hallucinogenic mushrooms by young people].
    Lassen JF; Lassen NF; Skov J
    Ugeskr Laeger; 1992 Sep; 154(39):2678-81. PubMed ID: 1413197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe rhabdomyolysis, acute renal failure and posterior encephalopathy after 'magic mushroom' abuse.
    Bickel M; Ditting T; Watz H; Roesler A; Weidauer S; Jacobi V; Gueller S; Betz C; Fichtlscherer S; Stein J
    Eur J Emerg Med; 2005 Dec; 12(6):306-8. PubMed ID: 16276262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liquid chromatography-mass spectrometric and liquid chromatography-tandem mass spectrometric determination of hallucinogenic indoles psilocin and psilocybin in "magic mushroom" samples.
    Kamata T; Nishikawa M; Katagi M; Tsuchihashi H
    J Forensic Sci; 2005 Mar; 50(2):336-40. PubMed ID: 15813544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pharmacology of psilocybin.
    Passie T; Seifert J; Schneider U; Emrich HM
    Addict Biol; 2002 Oct; 7(4):357-64. PubMed ID: 14578010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concise large-scale synthesis of psilocin and psilocybin, principal hallucinogenic constituents of "magic mushroom".
    Shirota O; Hakamata W; Goda Y
    J Nat Prod; 2003 Jun; 66(6):885-7. PubMed ID: 12828485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poisonings resulting from the ingestion of magic mushrooms in Kraków.
    Satora L; Goszcz H; Ciszowski K
    Przegl Lek; 2005; 62(6):394-6. PubMed ID: 16225077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psilocybin: from ancient magic to modern medicine.
    Nichols DE
    J Antibiot (Tokyo); 2020 Oct; 73(10):679-686. PubMed ID: 32398764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hallucinogenic mushrooms.
    Schwartz RH; Smith DE
    Clin Pediatr (Phila); 1988 Feb; 27(2):70-3. PubMed ID: 3338231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enzyme-assisted synthesis of the glucuronide conjugate of psilocin, an hallucinogenic component of magic mushrooms.
    Shoda T; Fukuhara K; Goda Y; Okuda H
    Drug Test Anal; 2011 Sep; 3(9):594-6. PubMed ID: 21960543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations between psychedelic use, abuse, and dependence and lifetime panic attack history in a representative sample.
    Bonn-Miller MO; Bernstein A; Sachs-Ericsson N; Schmidt NB; Zvolensky MJ
    J Anxiety Disord; 2007; 21(5):730-41. PubMed ID: 17067775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hallucinogens, amphetamines and entactogens].
    Vollenweider FX; Vollenweider-Scherpenhuyzen MF
    Ther Umsch; 2003 Jun; 60(6):323-8. PubMed ID: 12848067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Microscopic study of powders of hallucinogenic mushrooms--Psilocybe sp].
    Schäfer AT
    Arch Kriminol; 2000; 205(1-2):30-6. PubMed ID: 10726173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of 'magic mushroom' consumption.
    Morton E; Sakai K; Ashtari A; Pleet M; Michalak EE; Woolley J
    J Psychopharmacol; 2023 Jan; 37(1):49-60. PubMed ID: 36515370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presence of phenylethylamine in hallucinogenic Psilocybe mushroom: possible role in adverse reactions.
    Beck O; Helander A; Karlson-Stiber C; Stephansson N
    J Anal Toxicol; 1998; 22(1):45-9. PubMed ID: 9491968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychotropic drugs in developmental mushrooms: a case study review.
    Gross ST
    J Forensic Sci; 2002 Nov; 47(6):1298-302. PubMed ID: 12455653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Suicide under the influence of "magic mushrooms"].
    Müller K; Püschel K; Iwersen-Bergmann S
    Arch Kriminol; 2013; 231(5-6):193-8. PubMed ID: 23878898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Levels of psilocybin and psilocin in various types of mushrooms].
    Stríbrný J; Borovicka J; Sokol M
    Soud Lek; 2003 Jul; 48(3):45-9. PubMed ID: 14631713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The determination of psilocin and psilocybin in hallucinogenic mushrooms by HPLC utilizing a dual reagent acidic potassium permanganate and tris(2,2'-bipyridyl)ruthenium(II) chemiluminescence detection system.
    Anastos N; Lewis SW; Barnett NW; Sims DN
    J Forensic Sci; 2006 Jan; 51(1):45-51. PubMed ID: 16423222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.